My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 105

1.

Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Westermann D, Walther T, Savvatis K, Escher F, Sobirey M, Riad A, Bader M, Schultheiss HP, Tschöpe C.

Diabetes. 2009 Jun;58(6):1373-81. Epub 2009 Mar 10.PMID: 19276445 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.

Westermann D, Rutschow S, Van Linthout S, Linderer A, Bücker-Gärtner C, Sobirey M, Riad A, Pauschinger M, Schultheiss HP, Tschöpe C.

Diabetologia. 2006 Oct;49(10):2507-13. Epub 2006 Aug 26.PMID: 16937126 [PubMed - indexed for MEDLINE]Related articles

3.

Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor.

Westermann D, Lettau O, Sobirey M, Riad A, Bader M, Schultheiss HP, Tschöpe C.

Biol Chem. 2008 Jun;389(6):713-8.PMID: 18627295 [PubMed - indexed for MEDLINE]Related articles

4.

Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.

Westermann D, Rutschow S, Jäger S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tschöpe C.

Diabetes. 2007 Mar;56(3):641-6.PMID: 17327431 [PubMed - indexed for MEDLINE]Related articlesFree article

5.

Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy.

Tschöpe C, Walther T, Escher F, Spillmann F, Du J, Altmann C, Schimke I, Bader M, Sanchez-Ferrer CF, Schultheiss HP, Noutsias M.

FASEB J. 2005 Dec;19(14):2057-9. Epub 2005 Aug 29.PMID: 16129698 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.

Van Linthout S, Riad A, Dhayat N, Spillmann F, Du J, Dhayat S, Westermann D, Hilfiker-Kleiner D, Noutsias M, Laufs U, Schultheiss HP, Tschöpe C.

Diabetologia. 2007 Sep;50(9):1977-86. Epub 2007 Jun 23.PMID: 17589825 [PubMed - indexed for MEDLINE]Related articles

7.

Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus.

Thandavarayan RA, Watanabe K, Ma M, Gurusamy N, Veeraveedu PT, Konishi T, Zhang S, Muslin AJ, Kodama M, Aizawa Y.

Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H911-9. Epub 2009 Jul 17.PMID: 19617408 [PubMed - indexed for MEDLINE]Related articles

8.

Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy.

Spillmann F, Altmann C, Scheeler M, Barbosa M, Westermann D, Schultheiss HP, Walther T, Tschöpe C.

Int Immunopharmacol. 2002 Dec;2(13-14):1823-32.PMID: 12489796 [PubMed - indexed for MEDLINE]Related articles

9.

Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.

Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ.

J Am Coll Cardiol. 2006 Oct 17;48(8):1688-97. Epub 2006 Sep 27.PMID: 17045908 [PubMed - indexed for MEDLINE]Related articles

10.

G-protein signaling participates in the development of diabetic cardiomyopathy.

Harris IS, Treskov I, Rowley MW, Heximer S, Kaltenbronn K, Finck BN, Gross RW, Kelly DP, Blumer KJ, Muslin AJ.

Diabetes. 2004 Dec;53(12):3082-90.PMID: 15561937 [PubMed - indexed for MEDLINE]Related articlesFree article

11.

Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling.

Tschöpe C, Westermann D.

Biol Chem. 2008 Jun;389(6):707-11. Review.PMID: 18627288 [PubMed - indexed for MEDLINE]Related articles

12.

Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.

Zhou G, Li X, Hein DW, Xiang X, Marshall JP, Prabhu SD, Cai L.

J Am Coll Cardiol. 2008 Aug 19;52(8):655-66.PMID: 18702970 [PubMed - indexed for MEDLINE]Related articles

13.

Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.

Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J.

Cardiovasc Res. 2007 Jan 1;73(1):130-42. Epub 2006 Oct 27.PMID: 17137568 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction.

Xu J, Carretero OA, Sun Y, Shesely EG, Rhaleb NE, Liu YH, Liao TD, Yang JJ, Bader M, Yang XP.

Hypertension. 2005 Apr;45(4):747-53. Epub 2005 Feb 7.PMID: 15699461 [PubMed - indexed for MEDLINE]Related articlesFree article

15.

Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling.

Wang Y, Feng W, Xue W, Tan Y, Hein DW, Li XK, Cai L.

Diabetes. 2009 Jun;58(6):1391-402. Epub 2009 Mar 26.PMID: 19324938 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice.

Subramanian V, Krishnamurthy P, Singh K, Singh M.

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H673-83. Epub 2006 Sep 15.PMID: 16980342 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes.

Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H453-61. Epub 2008 Dec 5.PMID: 19060127 [PubMed - indexed for MEDLINE]Related articles

18.

Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.

Bilim O, Takeishi Y, Kitahara T, Arimoto T, Niizeki T, Sasaki T, Goto K, Kubota I.

Cardiovasc Diabetol. 2008 Feb 4;7:2.PMID: 18241357 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy.

Thandavarayan RA, Watanabe K, Ma M, Veeraveedu PT, Gurusamy N, Palaniyandi SS, Zhang S, Muslin AJ, Kodama M, Aizawa Y.

Biochem Pharmacol. 2008 May 1;75(9):1797-806. Epub 2008 Feb 12.PMID: 18342293 [PubMed - indexed for MEDLINE]Related articles

20.

Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI).

Yu X, Tesiram YA, Towner RA, Abbott A, Patterson E, Huang S, Garrett MW, Chandrasekaran S, Matsuzaki S, Szweda LI, Gordon BE, Kem DC.

Cardiovasc Diabetol. 2007 Feb 19;6:6.PMID: 17309798 [PubMed - indexed for MEDLINE]Related articlesFree article

Supplemental Content

Filter your results:

Find related data

Recent activity